Tina Shah

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction
    Tina Shah
    Centre for Clinical Pharmacology, University College London, United Kingdom
    Circ Cardiovasc Genet 3:436-44. 2010
  2. ncbi Detecting, predicting and modifying cardiovascular risk: new and developing strategies
    Tina Shah
    Centre for Clinical Pharmacology, British Heart Foundation Laboratories at UCL, Rayne Building, 5 University Street, London, WC1E 6JJ, UK
    Expert Rev Cardiovasc Ther 8:1519-21. 2010
  3. ncbi Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms
    Reecha Sofat
    Centre for Clinical Pharmacology, Department of Medicine, University College London, London, United Kingdom
    Circulation 121:52-62. 2010
  4. ncbi Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration
    Aspasia Angelakopoulou
    Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Eur Heart J 33:393-407. 2012
  5. ncbi Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream
    Eric J Brunner
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London, United Kingdom
    PLoS Med 5:e155. 2008
  6. ncbi Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip
    Philippa J Talmud
    Centre for Cardiovascular Genetics, Department of Medicine, University College London, London WC1E 6JF, UK
    Am J Hum Genet 85:628-42. 2009
  7. ncbi CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis
    Michael V Holmes
    Genetic Epidemiology Group, Department of Epidemiology and Public Health, University College London, 1 19 Torrington Pl, London, WC1E 6BT, United Kingdom
    JAMA 306:2704-14. 2011
  8. ncbi Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip
    Delilah Zabaneh
    University College London Genetics Institute, Department of Genetics, Environment and Evolution, London, UK
    Ann Hum Genet 75:456-67. 2011
  9. ncbi Blood pressure loci identified with a gene-centric array
    Toby Johnson
    Clinical Pharmacology and Barts and The London Genome Centre, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK
    Am J Hum Genet 89:688-700. 2011
  10. ncbi C-reactive protein gene variant and the human left ventricular growth response to exercise: data from The LARGE Heart Study
    Jack J Mann
    Centre for Cardiovascular Genetics, BHF Laboratories, Royal Free and University CollegeMedical School, London, UK
    J Cardiovasc Pharmacol 55:26-9. 2010

Detail Information

Publications15

  1. ncbi Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction
    Tina Shah
    Centre for Clinical Pharmacology, University College London, United Kingdom
    Circ Cardiovasc Genet 3:436-44. 2010
    ..Most observational studies of CRP and cardiovascular disease have been in Europeans. We evaluated the influence of ancestry on population CRP concentration to assess the implications for statin targeting in non-Europeans...
  2. ncbi Detecting, predicting and modifying cardiovascular risk: new and developing strategies
    Tina Shah
    Centre for Clinical Pharmacology, British Heart Foundation Laboratories at UCL, Rayne Building, 5 University Street, London, WC1E 6JJ, UK
    Expert Rev Cardiovasc Ther 8:1519-21. 2010
    ..This article focuses on some of these factors, as well as risk prediction and detection, and concludes with the current state of antiatherogenic treatment strategies...
  3. ncbi Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms
    Reecha Sofat
    Centre for Clinical Pharmacology, Department of Medicine, University College London, London, United Kingdom
    Circulation 121:52-62. 2010
    ..We hypothesized that common single-nucleotide polymorphisms in the CETP gene could help distinguish mechanism-based from off-target actions of CETP inhibitors to inform on the validity of CETP as a therapeutic target...
  4. ncbi Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration
    Aspasia Angelakopoulou
    Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
    Eur Heart J 33:393-407. 2012
    ....
  5. ncbi Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream
    Eric J Brunner
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London, United Kingdom
    PLoS Med 5:e155. 2008
    ..Our objective was to examine the nature of the association between CRP phenotype and diabetes development using CRP haplotypes as instrumental variables...
  6. ncbi Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip
    Philippa J Talmud
    Centre for Cardiovascular Genetics, Department of Medicine, University College London, London WC1E 6JF, UK
    Am J Hum Genet 85:628-42. 2009
    ..These genes provide further insights into lipid metabolism and the likely effects of modifying the encoded targets therapeutically...
  7. ncbi CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis
    Michael V Holmes
    Genetic Epidemiology Group, Department of Epidemiology and Public Health, University College London, 1 19 Torrington Pl, London, WC1E 6BT, United Kingdom
    JAMA 306:2704-14. 2011
    ....
  8. ncbi Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip
    Delilah Zabaneh
    University College London Genetics Institute, Department of Genetics, Environment and Evolution, London, UK
    Ann Hum Genet 75:456-67. 2011
    ..These data demonstrate that multiple common alleles with small effects make, in combination, important contributions to individual differences in vWF levels...
  9. ncbi Blood pressure loci identified with a gene-centric array
    Toby Johnson
    Clinical Pharmacology and Barts and The London Genome Centre, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK
    Am J Hum Genet 89:688-700. 2011
    ....
  10. ncbi C-reactive protein gene variant and the human left ventricular growth response to exercise: data from The LARGE Heart Study
    Jack J Mann
    Centre for Cardiovascular Genetics, BHF Laboratories, Royal Free and University CollegeMedical School, London, UK
    J Cardiovasc Pharmacol 55:26-9. 2010
    ..68 mg/L higher than carriers of the C allele...
  11. ncbi Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies
    Michael V Holmes
    Centre for Clinical Pharmacology, University College London, London, United Kingdom
    PLoS ONE 4:e7960. 2009
    ..Studies of the genetic basis of drug response could help clarify mechanisms of drug action/metabolism, and facilitate development of genotype-based predictive tests of efficacy or toxicity (pharmacogenetics)...
  12. ncbi C-reactive protein and coronary heart disease: predictive test or therapeutic target?
    Aroon D Hingorani
    Division of Population Sciences, Department of Epidemiology and Public Health, University College London, London, UK
    Clin Chem 55:239-55. 2009
    ..The research has encompassed observational and genetic epidemiology, basic science studies with cells and tissues, experiments with animal models and humans, and randomized trials (although not of specific CRP-lowering therapies as yet)...
  13. ncbi Insight into the nature of the CRP-coronary event association using Mendelian randomization
    Juan P Casas
    Centre for Clinical Pharmacology, Department of Medicine, BHF Laboratories at University College London, UCL, London, UK
    Int J Epidemiol 35:922-31. 2006
    ..Since the distribution of this polymorphism occurs at random during gamete formation, its association with coronary events should not be biased or confounded...
  14. ncbi Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study
    Mika Kivimaki
    Department of Epidemiology and Public Health, University College London, London, United Kingdom
    PLoS ONE 3:e3013. 2008
    ....
  15. ncbi Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
    Tina Shah
    Centre for Clinical Pharmacology, University College London, London, UK
    Int J Epidemiol 38:217-31. 2009
    ..Non-uniform reporting of relevant relationships and metrics hampers critical appraisal of the clinical utility of C-reactive protein (CRP) measurement for prediction of later coronary events...